FRONTEO Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) is an AI medical device "Severe fall prediction AI program" face-to-face advice with the Pharmaceuticals and Medical Devices Agency (PMDA). I would like to inform you that the preparatory interview has ended.The face-to-face advice preparation interview is one of the processes in the development of medical devices.

　This medical device uses AI to analyze the text written in the electronic medical record, and for each inpatient, falls leading to serious medical accidents^*risk assessment.

　With the advent of a super-aging society, the aging of patients is progressing rapidly at medical institutions, and dealing with the risk of falls during hospitalization has become a major issue.Falls and falls in the elderly not only lead to the need for nursing care, bedridden conditions, and the progression of dementia, but can also lead to death. The actual situation is that there is a limit to the response while the work of the workers is busy.

　FRONTEO will contribute to improving the quality of medical care and the QOL of patients by solving problems in the medical field by utilizing its in-house developed AI, which has strengths in natural language processing.

　The impact of this matter alone on the business results for the current fiscal year is minor, but we will promptly notify you if there are any matters to be disclosed.

* A fall leading to a serious medical accident: Changes in the patient resulting from the fall to the level requiring unplanned treatment or treatment, hospitalization, or prolonged hospitalization, such as fractures.

■ About FRONTEO　URL:https://www.fronteo.com/
FRONTEO is a data analysis company that uses the in-house developed AI engines KIBIT and Concept Encoder, Looca Cross specialized in natural language processing to extract meaningful and significant information from a large amount of textual data and support companies' business. Since its inception in August 2003, we have been working globally with Japan, the United States, Korea, and Taiwan, mainly in the Legaltech business, such as e-discovery (electronic evidence disclosure) and digital forensic surveys, which support company international lawsuits. Based on AI technology developed in this project, we have expanded our business fields to life science, business intelligence, and economic security since 8, and have used AI to transform textual data into knowledge, thus contributing to the resolution of various companies' issues, including support for drug discovery, support for dementia diagnostics, and support for financial, human resources, and business. Listed on TSE Mothers (currently TSE Growth) on June 2014, 2007. In January 6, the company obtained a license to manufacture and sell Class I medical devices (license number: 26B2021X1), and in September of the same year, the company submitted a notification to sell controlled medical devices (notification number: 13MinatoMiSeikikiDai1). Capital: ¥10350 (as of March 9, 3).

* FRONTEO, KIBIT, conceptencoder, and Looca Cross are registered trademarks of FRONTEO in Japan.